OECD Science, Technology and Industry Scoreboard 2011
Hide / Show Abstract

OECD Science, Technology and Industry Scoreboard 2011

This tenth edition of the OECD Science, Technology and Industry (STI) Scoreboard builds on the OECD’s 50 years of indicator development to present major world trends in knowledge and innovation. It analyses a wide set of indicators of science, technology, globalisation and industrial performance in OECD and major non-OECD countries (notably Brazil, the Russian Federation, India, Indonesia, China and South Africa) and includes some experimental indicators that provide insight into new areas of policy interest.

For more information about the OECD STI Scoreboard, see www.oecd.org/sti/scoreboard.

Click to Access: 
    http://oecd.metastore.ingenta.com/content/9211041e.pdf
  • PDF
  • http://www.keepeek.com/Digital-Asset-Management/oecd/science-and-technology/oecd-science-technology-and-industry-scoreboard-2011_sti_scoreboard-2011-en
  • READ
 
Chapter
 

Health innovation You or your institution have access to this content

English
Click to Access: 
    http://oecd.metastore.ingenta.com/content/9211041ec035.pdf
  • PDF
  • http://www.keepeek.com/Digital-Asset-Management/oecd/science-and-technology/oecd-science-technology-and-industry-scoreboard-2011/health-innovation_sti_scoreboard-2011-35-en
  • READ
Author(s):
OECD

Hide / Show Abstract

OECD countries are faced with the health-care challenges of ageing populations and others, such as increasingly drug-resistant diseases and the risk of global pandemics. Innovation is a critical means of improving the capacity of health systems to address these problems while containing escalating costs. The public sector plays a significant role alongside business and non-profit organisations, by supporting R&D directly but also through the procurement of new treatments resulting from R&D. Government budget appropriations or outlays for R&D (GBAORD) indicate that direct government support of health-related R&D in OECD countries was about 0.1% of their combined GDP in 2008. The United States is by far the largest funder in both absolute and relative terms, at just over 0.3% of GDP spent on health R&D.
Also available in French
 
Visit the OECD web site